Cronos Group Inc. (CRON) Income Statement

NASDAQ: CRONRevenue, profits, margins and EPS over 10 years.

CRON 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+26.8%
$149.2M
2025 · hover or tap a bar for each year
2016: $412,322 (−87.9%)2017: $4.1M (+904.5%)2018: $12.1M (+192.7%)2019: $17.8M (+47.2%)2020: $46.7M (+161.9%)2021: $64.6M (+38.2%)2022: $86.7M (+34.4%)2023: $87.2M (+0.6%)2024: $117.6M (+34.8%)2025: $149.2M (+26.8%)
20162025
Gross profit+144.9%
$61.7M
2025 · hover or tap a bar for each year
2016: $1.5M (−40.8%)2017: $2.0M (+34.9%)2018: $6.2M (+210.5%)2019: −$13.2M (−312.7%)2020: −$25.8M2021: −$17.6M2022: $15.4M2023: $11.9M (−22.8%)2024: $25.2M (+111.6%)2025: $61.7M (+144.9%)
20162025
Operating income
−$17.8M
2025 · hover or tap a bar for each year
2016: −$2.1M (−481.1%)2017: −$7.8M2018: −$20.4M2019: −$118.5M2020: −$219.4M2021: −$292.0M2022: −$111.4M2023: −$84.8M2024: −$76.5M2025: −$17.8M
20162025
Net income−123.4%
−$9.6M
2025 · hover or tap a bar for each year
2016: −$1.2M (−530.8%)2017: $2.5M2018: −$21.6M (−956.1%)2019: $1.19B2020: −$73.1M (−106.1%)2021: −$396.1M2022: −$168.7M2023: −$74.0M2024: $41.1M2025: −$9.6M (−123.4%)
20162025
EPS (diluted)−81.2%
$0.03
2025 · hover or tap a bar for each year
2016: −$0.03 (−400.0%)2017: $0.022018: −$0.16 (−900.0%)2019: $0.042020: −$0.63 (−1,675.0%)2021: −$0.182022: −$0.482023: −$0.132024: $0.162025: $0.03 (−81.2%)
20162025
Net profit margin−41.4 pts
−6.4%
2025 · hover or tap a point for each year
2016: −290.8% (−298.9 pts)2017: 61.0% (+351.8 pts)2018: −178.5% (−239.5 pts)2019: 6,691.6% (+6,870.1 pts)2020: −156.5% (−6,848.2 pts)2021: −613.5% (−457.0 pts)2022: −194.5% (+419.0 pts)2023: −84.8% (+109.7 pts)2024: 34.9% (+119.7 pts)2025: −6.4% (−41.4 pts)
20162025

CRON revenue and net income

RevenueNet incomeNet margin (right axis)

Where CRON's revenue goes

2025
Revenue
$149.2M100.0%
Cost of revenue
−$87.5M−58.6%
Gross profit
$61.7M41.4%
Research & development
−$4.4M−3.0%
Sales, general & admin
−$63.8M−42.8%
Other operating expenses
−$11.3M−7.6%
Operating income
−$17.8M−12.0%
Interest & other income
$419,2130.3%
Income taxes
$14.4M9.7%
Net income
−$9.6M−6.4%

Each bar shows an amount and its share of revenue. CRON kept −6.4% of revenue as net income.

CRON profit margins

GrossOperatingNet

CRON growth rates

to 2025
1 year3 years5 years10 years
Revenue+26.8%+19.8%+26.1%+45.9%
Gross profit+144.9%+58.7%—+37.8%
Operating income————
Net income−123.4%———
EPS (diluted)−81.2%——+11.6%

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

CRON quarterly EPS vs estimates

Reported EPSAnalyst estimate

Cronos beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: November 5, 2026 (estimate $0.03).

CRON income statement

Cronos Group Inc. annual income statement
2025202420232022202120202019201820172016
Revenue$149.2M$117.6M$87.2M$86.7M$64.6M$46.7M$17.8M$12.1M$4.1M$412,322
Cost of revenue$87.5M$92.4M$75.3M$71.3M$82.2M$72.6M$31.1M$5.9M$2.0M$1.4M
Gross profit$61.7M$25.2M$11.9M$15.4M−$17.6M−$25.8M−$13.2M$6.2M$2.0M$1.5M
Research & development$4.4M$4.2M$5.8M$13.1M$21.8M$20.4M$9.1M$1.7M$2.4M$2.4M
Sales, general & admin$63.8M$76.8M$80.9M$100.7M$121.7M$130.3M$87.2M$24.0M$7.0M$2.8M
Total operating expenses$79.5M$101.7M$96.7M$126.9M$274.4M$193.6M$101.9M$26.7M−$7.8M$1.3M
Operating income−$17.8M−$76.5M−$84.8M−$111.4M−$292.0M−$219.4M−$118.5M−$20.4M−$7.8M−$2.1M
Interest income$40.0M$52.0M$46.5M$22.5M$9.1M$18.6M$1.27B$476,000—$4,923
Interest expense———$13,000$27,000$186,000$24.8M$78,559$100,198$240,030
Income before taxes−$17.4M$36.6M−$73.7M−$121.0M−$128.5M−$73.3M$875.7M−$20.9M−$3.0M−$1.8M
Income taxes−$14.4M−$3.4M−$3.2M$34.2M−$431,000$1.3M−$1.29B$359,022−$862,000−$572,187
Net income−$9.6M$41.1M−$74.0M−$168.7M−$396.1M−$73.1M$1.19B−$21.6M$2.5M−$1.2M
EBITDA−$3.4M−$50.2M−$71.8M−$91.3M−$150.1M−$66.0M−$115.2M−$18.8M−$5.4M−$851,000
EPS (diluted)$0.03$0.16−$0.13−$0.48−$0.18−$0.63$0.04−$0.16$0.02−$0.03
Gross margin41.4%21.4%13.7%17.8%−27.3%−55.3%−74.1%51.3%48.3%359.7%
Operating margin−12.0%−65.1%−97.2%−128.4%−452.2%−469.6%−664.2%−168.7%−187.9%−516.8%
Net margin−6.4%34.9%−84.8%−194.5%−613.5%−156.5%6,691.6%−178.5%61.0%−290.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CRON's financial statements (latest annual report filed February 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

CRON financial results

In fiscal year 2025 (ended December 31, 2025), Cronos reported revenue of $149.2 million, up 26.8% from the year before. It had a net loss of $9.6 million, a net profit margin of −6.4%. Diluted earnings per share came to $0.03. Over five years revenue grew at an average rate of 26.1% a year.

See the CRON stock overview for the latest quote and news, or the CRON chart for price history and technical indicators.

CRON income statement FAQ

What is Cronos's annual revenue?

Cronos reported total revenue of $149.2 million for fiscal year 2025, which ended on December 31, 2025. That was up 26.8% from $117.6 million the previous year.

Is Cronos profitable?

No. Cronos reported a net loss of $9.6 million in fiscal 2025, a net profit margin of −6.4%; its operating margin was −12.0%.

What is Cronos's gross margin?

Cronos's gross margin was 41.4% in fiscal 2025: for every $100 of revenue, Cronos kept $41 after the direct cost of its products and services.

How much does Cronos spend on research and development?

Cronos spent $4.4 million on research and development in fiscal 2025, 3.0% of revenue.

How fast is Cronos growing?

Revenue grew 26.1% a year on average over the last five fiscal years, from $46.7 million to $149.2 million.

What are Cronos's earnings per share?

Cronos earned $0.03 per diluted share in fiscal 2025, compared with $0.16 a year earlier.

When will Cronos report its next earnings?

Cronos is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens.

When does Cronos's fiscal year end?

Cronos's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 26, 2026.

Drug Manufacturers - Specialty & Generic income statements